Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.61% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.6% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOLD
2801
Gold.com Inc
GOLD
$1.27B
| $515K | ﹤0.01% |
64,200
-19,000
| -23% | -$160K |
|
2802
Arcos Dorados Holdings
ARCO
$1.66B
| $515K | ﹤0.01% |
+100,357
| New | +$521K |
|
|
STRR
2803
Star Equity Holdings
STRR
$37.5M
| $515K | ﹤0.01% |
33,410
+3,920
| +13% | +$73.1K |
|
|
MCF
2804
DELISTED
Contango Oil & Gas Co.
MCF
| $515K | ﹤0.01% |
50,400
-101,864
| -67% | -$1.05M |
|
|
ENG
2805
DELISTED
ENGlobal Corp
ENG
| $514K | ﹤0.01% |
42,579
+3,591
| +9% | +$39.6K |
|
|
CCM
2806
Concord Medical Services
CCM
$20.8M
| $513K | ﹤0.01% |
12,890
-510
| -4% | -$21.4K |
|
2807
Wolfspeed
WOLF
$1.64B
| $512K | ﹤0.01% |
19,900
-2,900
| -13% | -$74.9K |
|
2808
MediWound
MDWD
$179M
| $511K | ﹤0.01% |
9,486
+1,372
| +17% | +$73K |
|
2809
John Wiley & Sons Class A
WLY
$2.63B
| $511K | ﹤0.01% |
9,900
-48,300
| -83% | -$2.65M |
|
2810
Ultralife
ULBI
$120M
| $509K | ﹤0.01% |
123,844
-11,356
| -8% | -$49.9K |
|
|
CORV
2811
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $509K | ﹤0.01% |
162,613
+72,400
| +80% | +$264K |
|
|
ARCX
2812
DELISTED
Arc Logistics Partners LP
ARCX
| $507K | ﹤0.01% |
33,703
-11,997
| -26% | -$177K |
|
|
STRS
2813
DELISTED
STRATUS PPTYS INC
STRS
| $505K | ﹤0.01% |
20,700
-28,900
| -58% | -$579K |
|
2814
Dorchester Minerals
DMLP
$1.35B
| $504K | ﹤0.01% |
32,700
-30,300
| -48% | -$456K |
|
|
HMLP
2815
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $501K | ﹤0.01% |
26,600
-1,900
| -7% | -$35.1K |
|
|
CDTX
2816
DELISTED
Cidara Therapeutics
CDTX
| $498K | ﹤0.01% |
2,175
+835
| +62% | +$193K |
|
|
VRTV
2817
DELISTED
VERITIV CORPORATION
VRTV
| $497K | ﹤0.01% |
+9,900
| New | +$458K |
|
|
EEI
2818
DELISTED
Ecology and Environment
EEI
| $492K | ﹤0.01% |
49,700
+3,800
| +8% | +$38.6K |
|
|
OCRX
2819
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $491K | ﹤0.01% |
185,800
+16,700
| +10% | +$41.7K |
|
|
AV
2820
DELISTED
Aviva Plc
AV
| $490K | ﹤0.01% |
42,600
+30,200
| +244% | +$328K |
|
2821
Educational Development Corp
EDUC
$11.8M
| $489K | ﹤0.01% |
85,862
-17,200
| -17% | -$105K |
|
|
GOGL
2822
DELISTED
Golden Ocean Group
GOGL
| $489K | ﹤0.01% |
120,700
+41,540
| +52% | +$155K |
|
2823
Acco Brands
ACCO
$399M
| $487K | ﹤0.01% |
50,547
-301,100
| -86% | -$3.09M |
|
|
HWCC
2824
DELISTED
Houston Wire & Cable Company
HWCC
| $487K | ﹤0.01% |
78,600
+10,600
| +16% | +$61.3K |
|
2825
Cineverse
CNVS
$68.2M
| $486K | ﹤0.01% |
11,963
+4,901
| +69% | +$172K |
|
Similar funds
Jim Simons's Q3 2016 Portfolio in Review
As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Jim Simons opened 414 new positions and closed 416 in Q3 2016.
- Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.